Organogenesis Holdings, Inc. (ORGO)
4.21
0.00 (0.00%)
USD |
NASDAQ |
Jan 09, 16:00
4.23
+0.02
(+0.48%)
After-Hours: 20:00
Organogenesis Holdings Profit Margin (Quarterly): 14.30% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -1.34% |
| Celularity, Inc. | -436.7% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
| Theriva Biologics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.28% |
| Return on Assets | 0.21% |
| Return on Invested Capital | 0.24% |
| Gross Profit Margin (Quarterly) | 71.34% |
| Operating Margin (Quarterly) | 14.69% |
| Return on Net Operating Assets | 0.31% |